A review of QSAR studies to predict activity of ACE peptide inhibitors

Pharmaceutical Sciences

Volumn 20, Issue 3, 2014, Pages 122-129

  Jahangiri, Reyhaneh ^a   Soltani, Somaieh ^b   Barzegar, Abolfazl ^a  

^a UNIVERSITY OF TABRIZ   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

ACE inhibitor; Peptide; QSAR; Review

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FOSINOPRIL; RAMIPRIL; ZOFENOPRIL;

CARDIOVASCULAR RISK; DRUG POTENCY; ENZYME INHIBITION; HUMAN; IC50; PREDICTION; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW; RISK FACTOR;

EID: 84937154185     PISSN: 1735-403X     EISSN: 2383-2886     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Paulis L, Unger T. Novel therapeutic targets for hypertension. Nat Rev Cardiol 2010;7:431-441.
2. Thind GS. Angiotensin converting enzyme inhibitors: comparative structure, pharmacokinetics, and pharmacodynamics. Cardiovasc Drugs Ther 1990;4:199-206.
3. Phillips M, Ea S. B. Kimura. Levels of angiotensin and molecular biology of the tissue renin angiotensin and molecular biology of the tissue renin angiotensin systems Regul Pept 1993;43:1-20.
4. Soubrier F, Alhenc-Gelas F, Hubert C, Allegrini J, John M, Tregear G, et al. Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. PNAS 1988;85:9386-9390.
5. Smith CG, Vane JR. The Discovery of Captopril. The FASEB J 2003;17:788-789.
6. D. W. Cushman MaO. History of the design of captopril and related inhibitors of angiotensin converting enzyme. Hypertension 1991;17:589-592.
7. Jao C-L, Huang S-L, Hsu K-C. Angiotensin I-converting enzyme inhibitory peptides: Inhibition mode, bioavailability, and antihypertensive effects. BioMedicine 2012;2:130-136.
8. Tzakos AG, Gerothanassis IP. Domain-selective ligand-binding modes and atomic level pharmacophore refinement in angiotensin I converting enzyme (ACE) inhibitors. Chembiochem 2005;6:1089-1103.
9. He HL, Liu D, Ma CB. Review on the angiotensin-I-converting enzyme (ACE) inhibitor peptides from marine proteins. Appl Biochem Biotechnol 2013;169:738-749.
10. Sheih I, Fang TJ, Wu T-K. Isolation and characterisation of a novel angiotensin I-converting enzyme (ACE) inhibitory peptide from the algae protein waste. Food Chem 2009;115:279-284.
11. Jimsheena VK, Gowda LR. Arachin derived peptides as selective angiotensin I-converting enzyme (ACE) inhibitors: structure-activity relationship. Peptides 2010;31:1165-1176.
12. Kumar R, AK, RS, AB. Pharmacological review on Natural ACE inhibitors. Scholars Res Libr 2010;2:273-293.
13. Tanzadehpanah H, Asoodeh A, Saberi MR, Chamani J. Identification of a novel angiotensin-I converting enzyme inhibitory peptide from ostrich egg white and studying its interactions with the enzyme. Innov Food Sci Emerg Technol 2013;18:212-219.
14. Vercruysse L, Van Camp J, Smagghe G. ACE inhibitory peptides derived from enzymatic hydrolysates of animal muscle protein: a review. J Agric Food Chem 2005;53:8106-8115.
15. De Leo F, Panarese S, Gallerani R, Ceci LR. Angiotensin converting enzyme (ACE) inhibitory peptides: production and implementation of functional food. Curr Pharm Des 2009;15:3622-3643.
16. Soltani S, Abolhasani H, Zarghi A, Jouyban A. QSAR analysis of diaryl COX-2 inhibitors: comparison of feature selection and train-test data selection methods. Eur J Med Chem 2010;45:2753-2760.
17. Soltani S, Haghaei H, Shayanfar A, Vallipour J, Asadpour Zeynali K, Jouyban A. QSBR Study of Bitter Taste of Peptides: Application of GA-PLS in Combination with MLR, SVM, and ANN Approaches. BioMed Res Int 2013;2013:13.
18. Wu J, Aluko RE, Nakai S. Structural Requirements of Angiotensin I-Converting Enzyme Inhibitory Peptides: Quantitative Structure-Activity Relationship Modeling of Peptides Containing 4-10 Amino Acid Residues. QSAR Comb Sci 2006;25:873-880.
19. Mei H, Liao ZH, Zhou Y, Li SZ. A new set of amino acid descriptors and its application in peptide QSARs. Biopolymers 2005;80:775-786.
20. Tong J, Chen Y, Liu S, Che T, Xu X. A descriptor of amino acids SVWG and its applications in peptide QSAR. J Chemom 2012;26:549-555.
21. Tong J, Liu S, Zhou P, Wu B, Li Z. A novel descriptor of amino acids and its application in peptide QSAR. J Theor Biol 2008;253:90-97.
22. Long H-X, Wang Y-Q, Lin Y, Lin Z-H. QSAR Study on ACE Inhibitors by Using OSC-PLS Algorithm. J Chin Chem Soc 2010;57:417-422.
23. Jianbo Tong JC, Xiameng Xu, Shuling Liu, Mim Bai. A New Descriptor For Amino Acids And Its Applications In Peptide Qsar Revista De Chimie 2014;65:550-555.
24. Jing P, Qian B, He Y, Zhao X, Zhang J, Zhao D, et al. Screening milk-derived antihypertensive peptides using quantitative structure activity relationship (QSAR) modelling and in vitro/in vivo studies on their bioactivity. Int Dairy J 2014;35:95-101.
25. Jian-Bo Tong JC, Shu-Ling Liu and Min Bai. QSAR study of peptide drugs based on a new descriptor of amino acids - SVWGM. JIAN-BO TONG, JIA CHANG, SHU-LING LIU and MIN BAI 2014; in press.
26. Liang G, Yang L, Kang L, Mei H, Li Z. Using multidimensional patterns of amino acid attributes for QSAR analysis of peptides. Amino Acids 2009;37:583-591.
27. Shu M, Mei H, Yang S, Liao L, Li Z. Structural Parameter Characterization and Bioactivity Simulation Based on Peptide Sequence. QSAR Comb Sci 2009;28:27-35.
28. Tian F, Zhou P, Li Z. T-scale as a novel vector of topological descriptors for amino acids and its application in QSARs of peptides. J Mol Struct 2007;830:106-115.
29. Wang X, Wang J, Lin Y, Ding Y, Wang Y, Cheng X, et al. QSAR study on angiotensin-converting enzyme inhibitor oligopeptides based on a novel set of sequence information descriptors. J Mol Model 2011;17:1599-1606.
30. Hemmateenejad B, Yousefinejad S, Mehdipour AR. Novel amino acids indices based on quantum topological molecular similarity and their application to QSAR study of peptides. Amino Acids 2011;40:1169-1183.
31. Li Z, Li G, Shu M, Sun J, Yang S, Mei H, et al. A novel vector of topological and structural information for amino acids and its QSAR applications for peptides and analogues. Sci China Ser B-Chem 2008;51:946-957.
32. Zhihua L, Yuzhang W, Xuejun Q, Yuegang Z, Bing N, Ying W. Use of a novel electrotopological descriptor for the prediction of biological activity of peptide analogues. Lett Pept Sci 2002;9:273-281.
33. Yin J. Prediction of ACE Inhibitor Tripeptides Activity Based on Amino Acid Descriptors (E) from Multiple Linear Regression Model. Int Conf Bioinform Biomed Eng 2011. p. 1-4.
34. Lin Z-H, Long H-X, Bo Z, Wang Y-Q, Wu Y-Z. New descriptors of amino acids and their application to peptide QSAR study. Peptides 2008;29:1798-1805.
35. He R, Ma H, Zhao W, Qu W, Zhao J, Luo L, et al. Modeling the QSAR of ACE-Inhibitory Peptides with ANN and Its Applied Illustration. Int J Peptides 2012;2012.
36. Yin J, Diao Y, Wen Z, Wang Z, Li M. Studying Peptides Biological Activities Based on Multidimensional Descriptors (E) Using Support Vector Regression. Int J Pept Res Ther 2010;16:21-111.
37. Regulska K, Stanisz B, Regulski M, Murias M. How to design a potent, specific, and stable angiotensin-converting enzyme inhibitor. Drug Discovery Today 2014;19:1731-1743.
38. Pripp AH, Isaksson T, Stepaniak L, Sørhaug T. Quantitative structure-activity relationship modelling of ACE-inhibitory peptides derived from milk proteins. Eur Food Res Technol 2004;219:579-583.